Michael Ott
Pulmonary Disease · Eglin Afb, FLNPI 1629052725
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $733,563 of the $909,084 with a category attached, or 80.7%. GSK accounts for 99.3% of it on its own, with 11 other manufacturers making up the rest. Among pulmonary disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,110 payments — averaging $818.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$903K
- Grifols USA, LLC$5K
- Viiv Healthcare Company$600
- Boehringer Ingelheim$345
- Vapotherm Inc$101
- Inspire Medical Systems, Inc.$34
- plus $119 from 6 others
What the payments were for
- Consulting fees$9,4501%
- Speaking & faculty fees$733,56381%
- Travel & lodging$145,25216%
- Food & beverage$20,8022%
- Gifts$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 1,079 | $902,783 |
| Grifols USA, LLC | 6 | $5,102 |
| Viiv Healthcare Company | 1 | $600 |
| Boehringer Ingelheim | 11 | $345 |
| Vapotherm Inc | 4 | $101 |
| Inspire Medical Systems, Inc. | 2 | $34 |
| Gilead | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Merck | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Boston Scientific | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$315,524
- NUCALA$237,395
- AREXVY$169,225
- ANORO ELLIPTA$17,556
- ANORO$9,748
- Prolastin-C Liquid$5,087
How this compares
$909,084 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Eglin Afb
- Franck RahaghiWeston$1.2M
- Ali JiwaniOrlando$859K
- Anas HadehWeston$800K
- Jennifer FultonJacksonville$665K
- Ricardo Restrepo-JaramilloTampa$555K
- Mark RumbakTampa$528K
- Jose Soto SotoJacksonville$504K
- Javier Perez FernandezMiami$496K
- Domenick ReinaTampa$469K
- Jorge MalleaJacksonville$457K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.